Congratulations to Moximed for getting FDA approval for their new device, MISHA™ Knee System! Whenever I see an active patient with knee arthritis who has started to limit their activity, I run through a long list of options ranging from exercise modifications and physical therapy to injections to a knee replacement.
A common question I then get asked is: What is currently in development or what new surgery will be available to them if they can wait? By and large, the answer has been… nothing. I would sadly reply that here was nothing in development that can reverse degenerative arthritis.
However, there is a new device that may be able to decrease symptoms due to arthritis and delay or potentially avoid the need for arthroplasty. Moximed developed an implantable device for the knee that decreases the stress from activity and therefore the pain due to arthritis on the medial aspect of the knee.
While I haven’t used this device, my husband, Dr. Andreas Gomoll, participated in their clinical trials that led to the recent FDA approval. For now, I cannot tell patients that there is a clear way to avoid a knee replacement, but there is some hope that we may have better solutions to delay this surgery and decrease symptoms.
Read the press release.